KR970000237A - Composition for the Treatment of AIDS and Immune Function Enhancement - Google Patents

Composition for the Treatment of AIDS and Immune Function Enhancement Download PDF

Info

Publication number
KR970000237A
KR970000237A KR1019950016143A KR19950016143A KR970000237A KR 970000237 A KR970000237 A KR 970000237A KR 1019950016143 A KR1019950016143 A KR 1019950016143A KR 19950016143 A KR19950016143 A KR 19950016143A KR 970000237 A KR970000237 A KR 970000237A
Authority
KR
South Korea
Prior art keywords
aids
treatment
code
water extract
pharmaceutical
Prior art date
Application number
KR1019950016143A
Other languages
Korean (ko)
Other versions
KR0166570B1 (en
Inventor
신영오
이주실
이홍래
강춘
남정구
Original Assignee
이강추
국립보건원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 이강추, 국립보건원 filed Critical 이강추
Priority to KR1019950016143A priority Critical patent/KR0166570B1/en
Publication of KR970000237A publication Critical patent/KR970000237A/en
Application granted granted Critical
Publication of KR0166570B1 publication Critical patent/KR0166570B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying

Abstract

본 발명은 천축황(Bambusae Concretio Silicea), 그 물추출물질(Code No. 142), 또는 이물추출물질을 분획한 분획물질(Code Nos. 142-2A, 142-3F)을 에이즈(AIDS)의 치료 및 면역강화용으로 사용하는 방법. 그것을 유효성분으로 함유하는 제제 및 그 제조방법에 관한 것으로서, 본 발명의 물질들은 강력한 항 HIV 활성을 갖는다.The present invention is a treatment of AIDS (Bambusae Concretio Silicea), its water extract (Code No. 142), or the fraction material (Code Nos. 142-2A, 142-3F) fractionated foreign matter extract And methods for use in immunopotentiation. The present invention relates to a preparation containing the same as an active ingredient and a method for producing the same, wherein the substances of the present invention have potent anti-HIV activity.

Description

에이즈(AIDS)의 치료 및 면역기능강화용 조성물Composition for the Treatment of AIDS and Immune Function Enhancement

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음As this is a public information case, the full text was not included.

Claims (4)

천축황(Bambusae Concretio Silicea), 그 물추출물질(Code No. 142), 또는 이 물추출물질을 분획한 분획물질(Code Nos. 142-2A, 142-3E 및 142-3F)을 통상의 약제학적으로 사용되는 부형제와 통상의 약제학적으로 사용되는 방법으로 통상의 약제학적으로 사용되는 제제형태로 제제화하여 에이즈(AIDS)의 치료 및 면역강화용으로 사용하는 방법.Chemella (Bambusae Concretio Silicea), its water extract (Code No. 142), or its fractionated material (Code Nos. 142-2A, 142-3E and 142-3F) were prepared by conventional pharmaceutical preparations. Excipients used in the conventional pharmaceutical preparations and methods used in the form of pharmaceutical preparations used in the form of a conventional pharmaceutical method used for the treatment and immune strengthening of AIDS (AIDS). 천축황(Bambusae Concretio Silicea), 그 물추출물질(Code No. 142), 또는 이 물추출물질을 분획한 분획물질(Code Nos. 142-2A, 142-3E 및 142-3F)을 통상의 약제학적으로 사용되는 부형제와 통상의 약제학적으로 사용되는 방법으로 통상의 약제학적으로 사용되는 제제형태로 제제화시킨 에이즈(AIDS) 치료 및 면역강화용 제제.Chemella (Bambusae Concretio Silicea), its water extract (Code No. 142), or its fractionated material (Code Nos. 142-2A, 142-3E and 142-3F) were prepared by conventional pharmaceutical preparations. An excipient used as a pharmaceutical preparation for the treatment of AIDS (AIDS) and immune fortified in the form of a conventionally used pharmaceutical preparation in a conventional pharmaceutically used manner. 제2항에서, 약제학적으로 사용되는 제제형태가 산제, 정제, 캡슐제, 액제, 주사제, 연고제, 시럽제에서 선택된 제제형태인 에이즈(AIDS)의 치료 및 면역강화용 제제.According to claim 2, wherein the pharmaceutical form used in the form of a powder, tablets, capsules, liquids, injections, ointments, syrups for the treatment and treatment of AIDS (AIDS). 천축황(Bambusae Concretio Silicea), 그 물추출물질(Code No. 142)또는 이 물추출물질을 분획한 분획물질(Code Nos. 142-2A, 142-3E 및 142-3F)을 유효성분으로 함유하고, 통상의 약제학적으로 사용되는 부형제와 통상의 약제학적으로 사용되는 방법으로 통상의 약제학적으로 사용되는 제제형태로 제제화시켜서 에이즈(AIDS)치료 및 면역강화용 제제를 제조하는 방법.It contains an active ingredient (Bambusae Concretio Silicea), its water extract material (Code No. 142) or a fraction material (Code Nos. 142-2A, 142-3E and 142-3F) fractionated from the water extract material. To prepare a pharmaceutical preparation for the treatment of AIDS (AIDS) and immuno-enhanced by formulating in the form of a conventional pharmaceutical use in the form of a conventional pharmaceutically used excipient and a conventional pharmaceutically used method. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019950016143A 1995-06-17 1995-06-17 Pharmaceutical compositions for improvement of immune system and treatment of aids disease KR0166570B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019950016143A KR0166570B1 (en) 1995-06-17 1995-06-17 Pharmaceutical compositions for improvement of immune system and treatment of aids disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019950016143A KR0166570B1 (en) 1995-06-17 1995-06-17 Pharmaceutical compositions for improvement of immune system and treatment of aids disease

Publications (2)

Publication Number Publication Date
KR970000237A true KR970000237A (en) 1997-01-21
KR0166570B1 KR0166570B1 (en) 1999-01-15

Family

ID=19417397

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950016143A KR0166570B1 (en) 1995-06-17 1995-06-17 Pharmaceutical compositions for improvement of immune system and treatment of aids disease

Country Status (1)

Country Link
KR (1) KR0166570B1 (en)

Also Published As

Publication number Publication date
KR0166570B1 (en) 1999-01-15

Similar Documents

Publication Publication Date Title
RS49963B (en) Composition comprising a nutritious material and a herbal extract useful for prevention and treatment of human immunodeficiency virus and other infective diseases
DK0552256T3 (en) Method of treating or preventing type 1 diabetes by oral administration of insulin
FR2442054A1 (en) PURIFIED PROTEINS, IN PARTICULAR INTERFERON, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
NO20100061L (en) Prevention and treatment of amyloidogenic disease
DE3688114D1 (en) INCLUSION COMPLEXES OF 7-ISOPROPOXY-ISOFLAVON WITH CYCLODEXTRINES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE INCLUSION COMPLEXES.
ATE246496T1 (en) SPHEROIDS, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL FORMS CONTAINING SAME
ATE217525T1 (en) SPHEROIDS CONTAINING TIAGABINE, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING SAME
FR2708198B1 (en) Cosmetic or pharmaceutical composition, in particular dermatological composition containing an extract of Tephrosia, in particular Tephrosia purpurea.
YU166790A (en) COMPLEXES THAT HAVE AUXILIARY ACTIVITY
EP0354554A3 (en) Anti-irritant and desensitizing compositions and methods of their use
AU4101589A (en) Pharmaceutical preparations which can be applied transdermally, containing sterolins and/or spiroketalins
AU1226288A (en) Processes for the preparation of medicinal compositions, compositions obtained by these processes and use thereof for the preparation of medicines against viral hepatitis b and acquired immunodeficiency syndrome
ES2195039T3 (en) USE OF A MEDICINAL PRODUCT AND USE OF A MIXTURE OF SUBSTANCES FOR THE PREPARATION OF A MEDICINAL PRODUCT.
CA2238278A1 (en) Antigenic protein originating in malassezia
YU67492A (en) PROCEDURE FOR OBTAINING A PHARMACEUTICAL MEDICINAL PRODUCT
KR970000237A (en) Composition for the Treatment of AIDS and Immune Function Enhancement
KR960700741A (en) METHOD OF TREATING HEPATITIS C IN NON-PESPONDERS TO INTERFERON TREATMENT
CA2093914A1 (en) Antineoplastic drug of plant extraction and process for the preparation thereof
FR2700268B1 (en) Cosmetic or pharmaceutical composition, especially dermatological, containing an extract of Vismia.
ATE293445T1 (en) PRODUCTION OF PURE STEREOISOMERS OF TRICYCLO-(5.2.1.0(2.6))-DEC-9-YL-XANTHOGENATE AND THEIR USE AS MEDICINAL PRODUCTS
DE59000712D1 (en) EXTRACT MEDICINAL PRODUCTS.
AU2229997A (en) Pharmaceutical compositions comprising natural human alpha-interferon
PT100526A (en) CHEMOTHERAPEUTIC AGENTS OF PLANT ORIGIN WITH ANTINEOPLASTIC ACTIVITY, POSSESSING HIGH SELECTIVITY AND VERY REDUCED TOXICITY AND PROCESS FOR THEIR PREPARATION
KR950002770A (en) Method for extracting pinusolide from the temporal lobe and PAF-antagonist containing it as main ingredient
EP0955054A4 (en) Aids remedy

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
EXPY Expiration of term